Metrion Biosciences

Metrion Biosciences is a unique company that is deeply specialized in Ion Channel drug discovery. With a dedicated team of seasoned experts, the firm offers unrivaled knowledge and expertise in the field of drug discovery. Metrion Biosciences is recognized globally for its integrity and reliability in conducting complex and critical research. The company also ensures regulatory compliance by being a part of the UK GLP (Good Laboratory Practice) Compliance Monitoring Programme, enabling it to provide GLP-compliant hERG ion channel screening services to the life sciences community globally.

Founded on its world-class ion channel expertise, Metrion Biosciences provides a wide range of services to its clients. These encompass Ion Channel Screening and Neuroscience services, Cardiac Safety Screening, Translational Assays, and Integrated Drug Discovery, to name a few. Bolstering their technical prowess is their continual capacity expansion; this is evident in their feat to extend their Senior Leadership Team, with the appointment of Dr. Robert Kirby as Chief Operating Officer and Dr. Edward Stevens as Chief Scientific Officer. The company demonstrates its commitment to advancing knowledge and understanding about Ion Channels by keeping an up-to-date knowledge library alongside providing resources such as white papers, case studies, and publications.

Metrion Biosciences is not just a company; it's a nexus where avid researchers, sci-tech enthusiasts, and pharmaceutical professionals globally connect to explore new horizons in drug discovery and related fields. The company's commitment to fostering knowledge dissemination and its pursuit of pioneering research makes it an organization worth exploring for anyone interested in the scientific field, particularly medicine and pharmacology. Their story of continual growth and expansion, coupled with the ability to deliver quality results, makes them a beacon in their niche in the industry.

Connect